Evoke Pharma, Inc. ( EVOK) - Key Metrics
Stock symbol EVOK is outdated, potentially delisted? Maybe it is available on other exchange?
EVOK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $1.47 | -$0.62 | -$0.22 | -$0.22 |
| 2025Q1 | $1.21 | -$0.51 | -$0.39 | -$0.39 |
| 2024Q4 | $2.23 | -$0.80 | -$0.83 | -$0.83 |
| 2024Q3 | $1.90 | -$0.94 | -$0.58 | -$0.58 |
| 2024Q2 | $1.87 | -$0.93 | -$0.60 | -$0.60 |
EVOK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -1.06 |
| 2025Q1 | ? | -1.34 |
| 2024Q4 | ? | -1.38 |
| 2024Q3 | ? | -1.27 |
| 2024Q2 | ? | -1.52 |
EVOK
Price: $11
52 week price:
Earnings Per Share: -1.38 USD
P/E Ratio: -7.92
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 13353
Ebitda: -3.7 millionMarket Capitalization: 18.8 million